Natco Pharma is aiming to launch around 10 new products every year in the Indian market. The company’s strategy remains intact as it invests prudently in its research, manufacturing plants and enriching of skill sets. It has also some interesting filings and high-value launches in its international markets in the coming years. During the year, the company spent Rs 349 crore on capital expenditure, a majority of which was used to enhance capabilities of their manufacturing facilities.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
